Source: StemCells, Inc.
Date: November 30, 2007
Summary:
In an official company news release, Stem Cells, Inc., a biotechnology company in the field of stem cell research, announced that the first patient to receive a transplant of purified human neural stem cells in the Company's Phase I clinical trial has completed the trial. The patient, who was transplanted in November 2006, has finished the twelve-month period of immunosuppression and follow-up, and undergone the last of the tests and observations required by the trial protocol. As planned, the patient has subsequently been enrolled in a separate long-term follow-up study, designed to monitor the patients over a four-year period.
